The 2003 Canadian recommendations for dyslipidemia management: revisions are needed

CMAJ. 2005 Apr 12;172(8):1027-31. doi: 10.1503/cmaj.1040202.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Canada
  • Cholesterol, LDL / blood
  • Coronary Disease / mortality
  • Coronary Disease / prevention & control*
  • Cost-Benefit Analysis
  • Health Expenditures
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hyperlipidemias / drug therapy*
  • Hypolipidemic Agents / therapeutic use
  • Middle Aged
  • Practice Guidelines as Topic*
  • Risk Factors

Substances

  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents